| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 18 | 2021 | 79 | 4.720 |
Why?
|
| Computational Biology | 8 | 2021 | 190 | 2.070 |
Why?
|
| Gastrointestinal Microbiome | 8 | 2021 | 121 | 1.710 |
Why?
|
| Phylogeny | 9 | 2021 | 196 | 1.320 |
Why?
|
| Colorectal Neoplasms | 3 | 2021 | 560 | 1.170 |
Why?
|
| Models, Genetic | 7 | 2019 | 161 | 1.150 |
Why?
|
| Models, Statistical | 3 | 2019 | 446 | 1.070 |
Why?
|
| RNA, Ribosomal, 16S | 11 | 2020 | 85 | 0.970 |
Why?
|
| Dysbiosis | 3 | 2021 | 24 | 0.960 |
Why?
|
| Computer Simulation | 12 | 2019 | 705 | 0.910 |
Why?
|
| Mental Processes | 1 | 2023 | 22 | 0.900 |
Why?
|
| Phenotype | 4 | 2023 | 946 | 0.850 |
Why?
|
| Immunity | 1 | 2021 | 67 | 0.790 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 37 | 0.770 |
Why?
|
| Adenoma | 1 | 2021 | 132 | 0.740 |
Why?
|
| Hemoglobins | 1 | 2020 | 120 | 0.720 |
Why?
|
| Databases, Factual | 2 | 2021 | 621 | 0.710 |
Why?
|
| Blood Platelets | 1 | 2020 | 284 | 0.690 |
Why?
|
| Genome-Wide Association Study | 5 | 2019 | 240 | 0.680 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 179 | 0.670 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2019 | 756 | 0.670 |
Why?
|
| Evolution, Molecular | 5 | 2013 | 79 | 0.660 |
Why?
|
| Research Design | 1 | 2023 | 729 | 0.650 |
Why?
|
| Software | 7 | 2019 | 418 | 0.640 |
Why?
|
| Metagenome | 7 | 2018 | 17 | 0.620 |
Why?
|
| Mouth | 4 | 2020 | 64 | 0.620 |
Why?
|
| Stochastic Processes | 3 | 2018 | 27 | 0.590 |
Why?
|
| Anti-Bacterial Agents | 7 | 2023 | 1026 | 0.580 |
Why?
|
| Algorithms | 6 | 2021 | 1194 | 0.540 |
Why?
|
| Bacteria | 7 | 2017 | 193 | 0.530 |
Why?
|
| Alternative Splicing | 4 | 2008 | 93 | 0.500 |
Why?
|
| Databases, Genetic | 2 | 2020 | 52 | 0.480 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1039 | 0.470 |
Why?
|
| Humans | 44 | 2022 | 68525 | 0.470 |
Why?
|
| Host-Pathogen Interactions | 3 | 2019 | 69 | 0.460 |
Why?
|
| Autoantibodies | 4 | 2019 | 434 | 0.450 |
Why?
|
| Sequence Alignment | 4 | 2021 | 165 | 0.430 |
Why?
|
| Mice | 16 | 2023 | 8472 | 0.410 |
Why?
|
| Exons | 4 | 2008 | 122 | 0.410 |
Why?
|
| Biological Evolution | 2 | 2008 | 86 | 0.390 |
Why?
|
| Bacterial Translocation | 3 | 2019 | 27 | 0.390 |
Why?
|
| Animals | 24 | 2023 | 20877 | 0.380 |
Why?
|
| Alveolar Bone Loss | 2 | 2021 | 40 | 0.360 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 155 | 0.360 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 91 | 0.350 |
Why?
|
| Osteogenesis | 2 | 2023 | 152 | 0.350 |
Why?
|
| Disease | 2 | 2019 | 41 | 0.340 |
Why?
|
| Sequence Analysis, DNA | 3 | 2013 | 208 | 0.340 |
Why?
|
| Skin | 3 | 2016 | 451 | 0.320 |
Why?
|
| Genome | 2 | 2007 | 54 | 0.310 |
Why?
|
| Vertebrates | 1 | 2007 | 20 | 0.300 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 1046 | 0.300 |
Why?
|
| Prognosis | 3 | 2021 | 2093 | 0.300 |
Why?
|
| Colon | 2 | 2021 | 168 | 0.290 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 188 | 0.290 |
Why?
|
| Information Storage and Retrieval | 1 | 2007 | 49 | 0.290 |
Why?
|
| Feces | 4 | 2019 | 88 | 0.260 |
Why?
|
| Case-Control Studies | 9 | 2019 | 1548 | 0.260 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 2550 | 0.250 |
Why?
|
| HIV Infections | 3 | 2019 | 775 | 0.250 |
Why?
|
| Psoriasis | 2 | 2016 | 46 | 0.250 |
Why?
|
| HIV-1 | 2 | 2018 | 177 | 0.240 |
Why?
|
| Bias | 3 | 2019 | 148 | 0.240 |
Why?
|
| Male | 21 | 2021 | 37281 | 0.240 |
Why?
|
| Streptococcus mutans | 2 | 2013 | 11 | 0.240 |
Why?
|
| Gastrointestinal Tract | 2 | 2016 | 62 | 0.230 |
Why?
|
| Intestines | 2 | 2014 | 114 | 0.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2016 | 68 | 0.220 |
Why?
|
| Minocycline | 1 | 2023 | 61 | 0.220 |
Why?
|
| Female | 18 | 2021 | 38015 | 0.210 |
Why?
|
| Gene-Environment Interaction | 2 | 2019 | 31 | 0.210 |
Why?
|
| Metagenomics | 4 | 2018 | 11 | 0.210 |
Why?
|
| Genomics | 4 | 2017 | 167 | 0.210 |
Why?
|
| Operating Rooms | 1 | 2022 | 108 | 0.200 |
Why?
|
| Bisphosphonate-Associated Osteonecrosis of the Jaw | 1 | 2021 | 3 | 0.200 |
Why?
|
| Bacteroides fragilis | 1 | 2021 | 20 | 0.200 |
Why?
|
| Osteonecrosis | 1 | 2021 | 20 | 0.200 |
Why?
|
| Natural Language Processing | 1 | 2021 | 69 | 0.200 |
Why?
|
| Data Warehousing | 1 | 2021 | 21 | 0.190 |
Why?
|
| Biomarkers | 4 | 2020 | 1593 | 0.190 |
Why?
|
| Bone Density Conservation Agents | 1 | 2021 | 43 | 0.190 |
Why?
|
| Xenobiotics | 1 | 2020 | 17 | 0.190 |
Why?
|
| Periodontitis | 1 | 2021 | 47 | 0.190 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2012 | 92 | 0.190 |
Why?
|
| Survival Rate | 2 | 2020 | 1055 | 0.180 |
Why?
|
| Biological Ontologies | 1 | 2019 | 4 | 0.180 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 369 | 0.180 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 211 | 0.180 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 498 | 0.180 |
Why?
|
| Datasets as Topic | 1 | 2019 | 52 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 320 | 0.180 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2264 | 0.180 |
Why?
|
| Middle Aged | 8 | 2021 | 21119 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 7 | 2023 | 2790 | 0.170 |
Why?
|
| Sexual Maturation | 1 | 2019 | 10 | 0.170 |
Why?
|
| Electronic Health Records | 1 | 2023 | 374 | 0.170 |
Why?
|
| Staphylococcus | 1 | 2019 | 29 | 0.170 |
Why?
|
| Methylmercury Compounds | 1 | 2019 | 19 | 0.170 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 799 | 0.170 |
Why?
|
| Mercury | 1 | 2019 | 34 | 0.170 |
Why?
|
| Antibodies, Antinuclear | 1 | 2019 | 171 | 0.170 |
Why?
|
| Systems Biology | 1 | 2018 | 25 | 0.170 |
Why?
|
| Graft vs Host Disease | 1 | 2021 | 163 | 0.170 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 90 | 0.170 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 56 | 0.160 |
Why?
|
| Tristetraprolin | 1 | 2018 | 9 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1293 | 0.160 |
Why?
|
| Autoantigens | 1 | 2018 | 91 | 0.160 |
Why?
|
| Pandemics | 1 | 2021 | 346 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 445 | 0.160 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 508 | 0.150 |
Why?
|
| Classification | 1 | 2017 | 8 | 0.150 |
Why?
|
| Family | 1 | 2019 | 293 | 0.150 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 455 | 0.150 |
Why?
|
| DNA, Ribosomal | 2 | 2019 | 59 | 0.150 |
Why?
|
| Lupus Nephritis | 1 | 2019 | 193 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2019 | 627 | 0.150 |
Why?
|
| Sodium Hypochlorite | 1 | 2016 | 6 | 0.150 |
Why?
|
| Baths | 1 | 2016 | 3 | 0.150 |
Why?
|
| Penicillin V | 1 | 2016 | 2 | 0.150 |
Why?
|
| Fluticasone | 1 | 2016 | 12 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 226 | 0.150 |
Why?
|
| Environmental Exposure | 1 | 2019 | 269 | 0.140 |
Why?
|
| Dermatitis, Atopic | 1 | 2016 | 17 | 0.140 |
Why?
|
| Dermatologic Agents | 1 | 2016 | 32 | 0.140 |
Why?
|
| Sample Size | 1 | 2016 | 79 | 0.140 |
Why?
|
| Genome, Bacterial | 2 | 2013 | 20 | 0.140 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2015 | 18 | 0.140 |
Why?
|
| Staphylococcus aureus | 2 | 2016 | 175 | 0.140 |
Why?
|
| Tylosin | 1 | 2015 | 1 | 0.140 |
Why?
|
| Amoxicillin | 1 | 2015 | 10 | 0.140 |
Why?
|
| Osteoarthritis, Knee | 1 | 2015 | 26 | 0.130 |
Why?
|
| Genetic Variation | 2 | 2013 | 220 | 0.130 |
Why?
|
| Likelihood Functions | 2 | 2012 | 105 | 0.130 |
Why?
|
| Penicillins | 1 | 2014 | 32 | 0.120 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2011 | 10 | 0.120 |
Why?
|
| Models, Biological | 3 | 2018 | 981 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 475 | 0.120 |
Why?
|
| Dental Caries | 1 | 2013 | 40 | 0.120 |
Why?
|
| Glucosyltransferases | 1 | 2013 | 28 | 0.110 |
Why?
|
| Aged | 5 | 2021 | 14842 | 0.110 |
Why?
|
| Methylcellulose | 1 | 2012 | 6 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 332 | 0.110 |
Why?
|
| Dietary Fiber | 1 | 2012 | 37 | 0.110 |
Why?
|
| RNA, Ribosomal, 5S | 1 | 2012 | 1 | 0.110 |
Why?
|
| Cultural Evolution | 1 | 2012 | 2 | 0.110 |
Why?
|
| Diabetic Foot | 1 | 2013 | 33 | 0.110 |
Why?
|
| RNA Splice Sites | 3 | 2007 | 13 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2798 | 0.110 |
Why?
|
| DNA Viruses | 1 | 2012 | 2 | 0.110 |
Why?
|
| Adiposity | 1 | 2012 | 88 | 0.100 |
Why?
|
| Drug Discovery | 1 | 2013 | 94 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 529 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 805 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2013 | 159 | 0.100 |
Why?
|
| Databases, Nucleic Acid | 2 | 2012 | 15 | 0.100 |
Why?
|
| Disease Progression | 2 | 2015 | 1037 | 0.100 |
Why?
|
| Sweden | 1 | 2011 | 21 | 0.100 |
Why?
|
| Databases, Bibliographic | 1 | 2011 | 14 | 0.100 |
Why?
|
| Language | 1 | 2012 | 120 | 0.100 |
Why?
|
| Major Histocompatibility Complex | 1 | 2011 | 34 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2011 | 31 | 0.100 |
Why?
|
| Genomic Instability | 1 | 2011 | 41 | 0.100 |
Why?
|
| Obesity | 2 | 2016 | 1074 | 0.090 |
Why?
|
| Canada | 1 | 2011 | 266 | 0.090 |
Why?
|
| Lymphoma | 1 | 2011 | 116 | 0.090 |
Why?
|
| Medical Informatics | 1 | 2011 | 71 | 0.090 |
Why?
|
| Aging | 1 | 2015 | 911 | 0.090 |
Why?
|
| Anopheles | 1 | 2008 | 3 | 0.080 |
Why?
|
| Caenorhabditis elegans | 1 | 2008 | 38 | 0.080 |
Why?
|
| Immunity, Innate | 2 | 2019 | 156 | 0.080 |
Why?
|
| Drosophila melanogaster | 1 | 2008 | 80 | 0.080 |
Why?
|
| Liver | 3 | 2023 | 1118 | 0.080 |
Why?
|
| Osteoclasts | 2 | 2019 | 132 | 0.080 |
Why?
|
| Mammals | 1 | 2007 | 47 | 0.070 |
Why?
|
| Database Management Systems | 1 | 2007 | 25 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 700 | 0.070 |
Why?
|
| United States | 3 | 2018 | 7335 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 693 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2022 | 3702 | 0.070 |
Why?
|
| Bayes Theorem | 3 | 2013 | 303 | 0.070 |
Why?
|
| Base Sequence | 1 | 2007 | 1015 | 0.060 |
Why?
|
| Metabolome | 2 | 2016 | 15 | 0.060 |
Why?
|
| Adult | 6 | 2019 | 21375 | 0.060 |
Why?
|
| DNA, Bacterial | 2 | 2019 | 150 | 0.060 |
Why?
|
| Markov Chains | 2 | 2018 | 133 | 0.060 |
Why?
|
| Drug Administration Schedule | 2 | 2016 | 567 | 0.060 |
Why?
|
| Rats | 4 | 2021 | 5300 | 0.060 |
Why?
|
| Reading Frames | 1 | 2004 | 1 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1446 | 0.060 |
Why?
|
| Genotype | 2 | 2018 | 785 | 0.060 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 563 | 0.060 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 186 | 0.060 |
Why?
|
| DNA | 2 | 2019 | 597 | 0.060 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 19 | 0.060 |
Why?
|
| Cholesterol | 2 | 2016 | 331 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 2077 | 0.060 |
Why?
|
| Phylogeography | 2 | 2012 | 4 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 492 | 0.050 |
Why?
|
| Sigmodontinae | 1 | 2021 | 3 | 0.050 |
Why?
|
| Jaw | 1 | 2021 | 4 | 0.050 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2021 | 17 | 0.050 |
Why?
|
| Isoantigens | 1 | 2021 | 26 | 0.050 |
Why?
|
| Semantics | 1 | 2021 | 37 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 785 | 0.050 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2021 | 33 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2021 | 120 | 0.050 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2020 | 1 | 0.050 |
Why?
|
| Allografts | 1 | 2021 | 63 | 0.050 |
Why?
|
| Young Adult | 3 | 2019 | 5708 | 0.050 |
Why?
|
| Diphosphonates | 1 | 2021 | 39 | 0.050 |
Why?
|
| Body Weight | 2 | 2012 | 554 | 0.050 |
Why?
|
| Staphylococcal Infections | 2 | 2013 | 156 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 1465 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2021 | 305 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 532 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 852 | 0.040 |
Why?
|
| Clostridiales | 1 | 2019 | 4 | 0.040 |
Why?
|
| Germinal Center | 1 | 2019 | 13 | 0.040 |
Why?
|
| Chemokine CCL3 | 1 | 2019 | 9 | 0.040 |
Why?
|
| Mesentery | 1 | 2019 | 17 | 0.040 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 21 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 68 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 35 | 0.040 |
Why?
|
| Time | 1 | 2019 | 57 | 0.040 |
Why?
|
| Programming Languages | 1 | 2018 | 16 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2018 | 84 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 245 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 18 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 98 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2019 | 79 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 32 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 50 | 0.040 |
Why?
|
| Probability | 1 | 2018 | 244 | 0.040 |
Why?
|
| Spleen | 1 | 2019 | 301 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2016 | 3185 | 0.040 |
Why?
|
| Alleles | 1 | 2019 | 386 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2019 | 258 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 689 | 0.040 |
Why?
|
| Virulence | 1 | 2017 | 51 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 397 | 0.040 |
Why?
|
| Fusobacteria | 1 | 2016 | 1 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 595 | 0.040 |
Why?
|
| Periodontium | 1 | 2016 | 11 | 0.040 |
Why?
|
| Kinetics | 1 | 2018 | 1047 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2018 | 489 | 0.040 |
Why?
|
| Aggregatibacter actinomycetemcomitans | 1 | 2016 | 18 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 2016 | 56 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2016 | 66 | 0.040 |
Why?
|
| Carrier State | 1 | 2016 | 39 | 0.040 |
Why?
|
| Homeostasis | 1 | 2018 | 291 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2019 | 682 | 0.040 |
Why?
|
| Porphyromonas gingivalis | 1 | 2016 | 33 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 265 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 138 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 333 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 626 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 249 | 0.030 |
Why?
|
| Time Factors | 2 | 2015 | 4655 | 0.030 |
Why?
|
| Child | 2 | 2019 | 6400 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2016 | 116 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1419 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 199 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 572 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 770 | 0.030 |
Why?
|
| Transcriptome | 1 | 2015 | 164 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2018 | 1692 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2015 | 222 | 0.030 |
Why?
|
| Age of Onset | 1 | 2013 | 188 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 648 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 219 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1851 | 0.030 |
Why?
|
| Genes, rRNA | 1 | 2013 | 8 | 0.030 |
Why?
|
| Arthrodermataceae | 1 | 2013 | 4 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2013 | 12 | 0.030 |
Why?
|
| Micrococcal Nuclease | 1 | 2013 | 7 | 0.030 |
Why?
|
| Forearm | 1 | 2013 | 25 | 0.030 |
Why?
|
| Hypromellose Derivatives | 1 | 2012 | 2 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 2012 | 6 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2013 | 24 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 40 | 0.030 |
Why?
|
| Prebiotics | 1 | 2012 | 10 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2013 | 49 | 0.030 |
Why?
|
| Biodiversity | 1 | 2012 | 16 | 0.030 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2012 | 6 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 2331 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2012 | 30 | 0.030 |
Why?
|
| Turkey | 1 | 2012 | 7 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2012 | 8 | 0.030 |
Why?
|
| Weaning | 1 | 2012 | 12 | 0.030 |
Why?
|
| Linguistics | 1 | 2012 | 10 | 0.030 |
Why?
|
| Cricetinae | 1 | 2013 | 262 | 0.030 |
Why?
|
| History, Ancient | 1 | 2012 | 25 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 2453 | 0.030 |
Why?
|
| Vocabulary | 1 | 2012 | 14 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2013 | 99 | 0.030 |
Why?
|
| Cecum | 1 | 2012 | 39 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2013 | 144 | 0.030 |
Why?
|
| Bone Development | 1 | 2012 | 37 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 81 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 778 | 0.030 |
Why?
|
| Agriculture | 1 | 2012 | 54 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2012 | 92 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 94 | 0.030 |
Why?
|
| Body Composition | 1 | 2012 | 119 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 170 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2013 | 111 | 0.030 |
Why?
|
| Bone Density | 1 | 2012 | 159 | 0.030 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2011 | 3 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2011 | 12 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2011 | 8 | 0.030 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2011 | 6 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2011 | 41 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2013 | 148 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2011 | 41 | 0.020 |
Why?
|
| Acetic Acid | 1 | 2010 | 14 | 0.020 |
Why?
|
| Archaea | 1 | 2010 | 7 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 62 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2011 | 97 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2011 | 74 | 0.020 |
Why?
|
| Patient Safety | 1 | 2013 | 202 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 546 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 144 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 244 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2010 | 49 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2011 | 135 | 0.020 |
Why?
|
| RNA | 1 | 2011 | 171 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 7264 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 194 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 2891 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 252 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 536 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 230 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 329 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 3256 | 0.020 |
Why?
|
| Patient Selection | 1 | 2013 | 592 | 0.020 |
Why?
|
| Proteomics | 1 | 2011 | 246 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 4843 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2009 | 155 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 1449 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 1860 | 0.020 |
Why?
|
| Proteins | 1 | 2011 | 473 | 0.020 |
Why?
|
| Introns | 1 | 2006 | 68 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 8903 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 5719 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 2083 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2006 | 230 | 0.020 |
Why?
|
| Internet | 1 | 2006 | 390 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 181 | 0.010 |
Why?
|